Empire Life Investments Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altria Group
MO
|
+$17.9M |
| 2 |
Philip Morris
PM
|
+$15.1M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$13M |
| 4 |
Occidental Petroleum
OXY
|
+$10.9M |
| 5 |
Ameren
AEE
|
+$8.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$21.2M |
| 2 |
Affiliated Managers Group
AMG
|
+$17.9M |
| 3 |
RPM International
RPM
|
+$16.5M |
| 4 |
Constellation Brands
STZ
|
+$11.9M |
| 5 |
JELD-WEN Holding
JELD
|
+$11.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.62% |
| 2 | Healthcare | 14.18% |
| 3 | Communication Services | 12.68% |
| 4 | Technology | 9.85% |
| 5 | Industrials | 9.46% |
Similar funds
Empire Life Investments's Q3 2019 Portfolio in Review
As of Q3 2019, Empire Life Investments held 100 positions worth $1.19B, down 3.5% from $1.24B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Empire Life Investments withdrew a net $52.8M in Q3 2019, closing 8 positions and reducing 33 holdings. Its most notable exit was Thermo Fisher Scientific, an estimated $8.26M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Empire Life Investments opened a new position in Dave & Buster's worth $4.19M.
- Empire Life Investments's largest Q3 2019 buy was Dave & Buster's: 107,667 shares worth $4.19M.
- Empire Life Investments added most to Altria Group in Q3 2019, an estimated $17.9M increase.
- Empire Life Investments's biggest Q3 2019 reduction was Dow Inc, cutting an estimated $21.2M.
- Empire Life Investments fully exited Thermo Fisher Scientific in Q3 2019, selling an estimated $8.26M.
- Empire Life Investments's ten largest holdings make up 31% of its $1.19B portfolio in Q3 2019.
- Empire Life Investments opened 3 new positions and closed 8 in Q3 2019.
- Empire Life Investments's portfolio value fell 3.5% quarter-over-quarter to $1.19B.
Based on Empire Life Investments's 13F filing for Q3 2019, filed 25 Oct 2019.